CD40 and COVID-19: Comparing 35 non-hospitalized and 11 hospitalized COVID-19 patients (Figure 7B) revealed that a few signatures were commonly enriched in all COVID-19 patients regardless of disease severity, including PCs, CD40 activated B cells, the alternative complement pathway, and the cell cycle.